Project ID: 831434-2 – Name of the PI: Ricard Cervera Segura / Gerard Espinosa Garriga (General coordinator: Marta Alarcón) – Title: Taxonomy, Treatment, Targets and Remission (3TR) – Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions. – Funding Agency: Innovative Medicines Initiative (EU – Horizon 2020 Framework Programme) – Amount of Funding: 1.573.843,00 EUR – Duration: 2019-2026

Project ID: PI20/01104 – Name of the PI: Gerard Espinosa Garriga / Laura Pelegrín Colás – Title: Estudio multimodal de imagen para el diagnostico y pronóstico de los pacientes con lupus eritematoso sistémico. – Funding Agency: Instituto de Salud Carlos III – Amount of Funding: 8.385,30 EUR – Duration: 2021-2023

Project ID: 806975-2 – Name of the PI: Manuel Ramos Casals – Title: New clinical endpoints in primary Sjögren’s syndrome: an interventional trial based on stratifying patients (NECESSITY). – Funding Agency: European Comission – Horizon 2020-Work Programme 2016-2017 – Amount of Funding: 207.618,75 EUR – Duration: 2019-2023

Project ID: SAF 2017- 88275-R – Name of the PI: Maria Cinta Cid Xutglà / Patricia Pérez Galán (Collaborator: José Hernández Rodríguez) – Title: Multicellular interactions in the progresión of chronic inflammatory diseases and lymphoproliferative disorders: 3D models to investigate tarf meted immune-therapies. – Funding Agency: Ministerio de Economía y Competitividad – Amount of Funding: 314.600,00 EUR – Duration: 2018-2020

Project ID: 731944 – Name of the PI: Manuel Ramos Casals – Title: HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome towards improved stratification, treatment and health policy (HARMONICS). – Funding Agency: ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO A – Amount of Funding: 238.125,00 EUR – Duration: 2017-2020

Project ID: 115565 – Name of the PI: Ricard Cervera Segura / Gerard Espinosa Garriga (General coordinator: Marta Alarcón) – Title: Molecular reclassification to find clinically useful biomarkers for systemic autoimmune diseases (PRECISESADS). – Funding Agency: Innovative Medicines Initiative (EU – Horizon 2020 Framework Programme) – Amount of Funding: 145.320,00 EUR – Duration: 2014-2018